Highline Wealth Partners’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $57.8K | Buy |
74
+5
| +7% | +$3.9K | 0.02% | 141 |
|
|
2025
Q1 | $57.1K | Buy |
69
+24
| +53% | +$19.8K | 0.02% | 126 |
|
|
2024
Q4 | $34.8K | Buy |
45
+20
| +80% | +$15.5K | 0.01% | 149 |
|
|
2024
Q3 | $22.2K | Sell |
25
-6
| -19% | -$5.32K | 0.01% | 181 |
|
|
2024
Q2 | $28.1K | Buy |
31
+16
| +107% | +$14.5K | 0.01% | 154 |
|
|
2024
Q1 | $11.7K | Hold |
15
| – | – | ﹤0.01% | 216 |
|
|
2023
Q4 | $8.74K | Hold |
15
| – | – | ﹤0.01% | 213 |
|
|
2023
Q3 | $8.06K | Hold |
15
| – | – | 0.01% | 202 |
|
|
2023
Q2 | $7.04K | Hold |
15
| – | – | ﹤0.01% | 170 |
|
|
2023
Q1 | $5.15K | Hold |
15
| – | – | ﹤0.01% | 178 |
|
|
2022
Q4 | $5.49K | Hold |
15
| – | – | ﹤0.01% | 173 |
|
|
2022
Q3 | $4.85K | Buy |
+15
| New | +$4.85K | ﹤0.01% | 164 |
|